Vitamin D and MS: trial activity

1RecruitingSafety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
2CompletedSafety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis
3CompletedVitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)
4RecruitingThe Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients
5CompletedVitamin D Pilot Study in Patients With Multiple Sclerosis
6Not yet recruitingEfficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)
7RecruitingA Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
8Active, not recruitingColecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
9CompletedCan Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis
10RecruitingSupplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment
11CompletedColecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
12RecruitingCohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis






Source: www.clinicaltrials.gov
"Let's hope something positive comes from all this activity."